Objective: This comprehensive article explores the emerging role of pharmacogenetics in optimizing treatment for chronic congenital anemias, including β-thalassemia, sickle cell disease (SCD), and rare erythropoietic disorders. It integrates a systematic review with an in-depth clinical analysis of …